Relationship between inflammation and microalbuminuria in prehypertension

Journal of Human Hypertension

Volumn 27, Issue 2, 2013, Pages 119-125

  Navarro Gonzalez J F ^a   Mora, C ^a   Muros, M ^a   Garcia J ^a   Donate, J ^a   Cazana V ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

inflammation; microalbuminuria; prehypertension; target organ damage; tumor necrosis factor ; urinary albumin excretion

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOLOGICAL PARAMETERS; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREHYPERTENSION; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

ADULT; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PREHYPERTENSION; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872136326     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2011.118     Document Type: Article

References (44)

1. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. and the National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
3. Chobanian AV. Prehypertension revisited. Hypertension 2006; 48: 812-814. (Pubitemid 44610983)
4. Karpha M, Lip GV. The pathophysiology of target organ damage in hypertension. Minerva Cardioangiol 2006; 54: 417-429. (Pubitemid 44689838)
5. Pedrinelli R, Dell'Omo G, Di Bello V, Pontremoli R, Mariani M. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. J Human Hypertens 2002; 16: 79-89. (Pubitemid 34182916)
6. Pontremoli R, Leoncini G, Viazzi F, Parodi D, Vaccaro V, Falqui V et al. Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension. J Am Soc Nephrol 2005; 16(Suppl 1): S39-S41. (Pubitemid 41725081)
7. Lee JE, Kim Y-G, Choi Y-H, Huh W, Kim DJ, Oh HY. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006; 47: 962-967. (Pubitemid 44297569)
8. Kim BJ, Lee HJ, Sung KC, Kim BS, Kang JH, Lee MH et al. Comparison of microalbuminuria in 2 blood pressure categories of prehypertensive subjects. Circ J 2007; 71: 1283-1287.
9. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA 2003; 290: 2945-2951. (Pubitemid 37505526)
10. Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-a) and essential hypertension. J Hum Hypertens 2005; 19: 149-154. (Pubitemid 40220638)
11. Navarro-González JF, Mora C, Muros M, Jarque A, Herrera H, García J. Association of tumor necrosis factor-a with early target organ damage in newly diagnosed patients with essential hypertensió n. J Hypertens 2008; 26: 2168-2175.
12. Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Jujii S et al. Plasma interleukin-6 and tumor necrosis factor-a can predict coronary endothelial dysfunction in hypertensive patients. Hypertens Res 2007; 30: 541-548. (Pubitemid 47083124)
13. Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease. Am J Hypertens 2004; 17: 568-573. (Pubitemid 38844982)
14. Sathiyapriya V, Selvaraj N, Nandeesha H, Bobby Z, Aparna A, Pavithran P. Association between protein bound sialic acid and high sensitivity C-reactive protein in prehypertension: A possible indication of underlying cardiovascular risk. Clin Exp Hypertens 2008; 30: 367-374. (Pubitemid 352009294)
15. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl 1): S1-S266.
16. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100. (Pubitemid 41623371)
17. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon III RO, Criqui M et al. Centers for Disease Control and Prevention; American Heart Association.Markers of inflammation and cardiovascular disease: Application to clinic and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511. (Pubitemid 36158056)
18. Pickup JC. Inflammation and activated innate immune system in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27: 813-823. (Pubitemid 38280558)
19. Navarro-González JF, Mora-Fernández C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008; 19: 433-442. (Pubitemid 351355386)
20. King DE, Egan BM, Mainous III AG, Geesey ME. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens (Greenwich) 2004; 6: 562-568.
21. Lakoski SG, Cushman M, Palmas W, Blumenthal R, D'Agostino RB, Herrington DM. The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2005; 46: 1869-1874.
22. Lee JE, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006; 47: 962-967. (Pubitemid 44297569)
23. Ogunniyi MO, Croft JB, Greenlund KJ, Giles WH, Mensah GA. Racial/ethnic differences in microalbuminuria among adults with prehypertension and hypertension: National Health and Nutrition Examination Survey (NHANES), 1999-2006. Am J Hypertens 2010; 23: 859-864.
24. Norton GR, Maseko M, Libhaber E, Libhaber C, Majane OHI, Dessein P et al. Is prehypertension an independent predictor of target organ changes in young-to-middle-aged persons of African descent? J Hypertens 2008; 26: 2279-2287.
25. Kim BJ, Lee HJ, Sung KC, Kim BS, Kang JH, Lee MH et al. Comparison of microalbuminuria in 2 blood pressure categories of prehypertensive subjects. Circ J 2007; 71: 1283-1287.
26. Palmieri V, Celentano A, Roman MJ, Simone G, Lewis MR, Best L et al. Fibrinogen and preclinical echocardiographic target organ damage: The Strong Heart study. Hypertension 2001; 38: 1068-1074. (Pubitemid 34252807)
27. Jastrzebski M, Czarnecka D, Rajzer M, Kawecka-Jaszca K. Increased levels of inflammatory markers in hypertensives with target organ damage. Kardiol Pol 2006; 64: 802-809. (Pubitemid 44510424)
28. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-226. (Pubitemid 19136363)
29. Ochodnicky P, Henning RH, Richard PE, van Dokkum RPE, de Zeeuw D. Microalbuminuria and endothelial dysfunction: Emerging targets for primary prevention of end-organ damage. J Cardiovascular Pharmacol 2006; 47(Suppl 2): S151-S162. (Pubitemid 44620205)
30. Clausen P, Jensen JS, Jensen G, Borch-Johnsen K, Feldt-Rasmussen B. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 2001; 103: 1869-1874. (Pubitemid 32328400)
31. Schlaich MP, Parnell MM, Ahlers BA, Finch S, Marshall T, Zhang WZ et al. Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects. Circulation 2004; 110: 3680-3686. (Pubitemid 39665257)
32. Erdogan D, Yildirim I, Ciftci O, Ozer I, Caliskan M, Gullu H et al. Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function. Circulation 2007; 115: 593-599. (Pubitemid 46226169)
33. Gianotti G, Doerries C, Mocharla PS, Mueller MF, Bahlmann FH, Horvath T et al. Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension. Relation to endothelial dysfunction. Hypertension 2010; 55: 1389-1397.
34. Zhang H, Park Y, Wu J, Chen XP, Lee S, Yang J et al. Role of TNF-a in vascular dysfunction. Clin Sci 2009; 116: 219-230.
35. Baud L, Ardaillou R. Tumor necrosis factor in renal injury. Miner Electrolyte Metab 1995; 21: 336-341.
36. Navarro JF, Mora-Fernández C. The role of TNF-a in diabetic nephropathy: Pathogenic and therapeutic implications. Cytokine Growth Factor Rev 2006; 17: 441-450. (Pubitemid 44803222)
37. Torre-Amione G, Kapadia S, Lee J, Bies RD, Levobitz R, Mann DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995; 92: 1487-1493.
38. Navarro JF, Milena FJ, Mora C, León C, García J. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: Effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. Am J Nephrol 2006; 26: 562-570. (Pubitemid 46143878)
39. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB et al. Tumor necrosis factor-a and tumor necrosis factor receptors in the failing human heart. Circulation 1996; 93: 704-711.
40. Pauletto P, Rattazzi M. Inflammation and hypertension: The search for a link. Nephrol Dial Transplant 2006; 21: 850-853.
41. Luft FC, Mervaala E, Muller DN, Gross V, Schmidt F, Park JK et al. Hypertensioninduced end-organ damage. A new transgenic approach to an old problem. Hypertension 1999; 33: 212-218. (Pubitemid 29065662)
42. Sun M, Chen M, Dawood F, Zurawska U, Lee JY, Parker T, Kassiri Z et al. Tumor necrosis factor-a mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 2007; 115: 1398-1407. (Pubitemid 46648375)
43. El-Menyar AA. Cytokines and myocardial dysfunction: State of the art. J Card Fail 2008; 14: 61-74. (Pubitemid 351146639)
44. Julius S. Borderline hypertension. Clin Exp Hypertens 1999; 21: 741-747. (Pubitemid 29325473)